Granahan Investment Management - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$560,000
-92.6%
27,775
-86.2%
0.01%
-92.1%
Q2 2021$7,520,000201,5120.14%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 2,062,991$7,014,0001.85%
RA Capital Management 2,428,571$8,257,0001.01%
Omega Fund Management, LLC 223,457$760,0000.49%
683 Capital Management, LLC 800,000$2,720,0000.42%
EcoR1 Capital, LLC 382,000$1,299,0000.33%
Eventide Asset Management 377,000$1,282,0000.08%
Palo Alto Investors LP 481,519$1,637,0000.08%
SABBY MANAGEMENT, LLC 200,000$680,0000.04%
BOURGEON CAPITAL MANAGEMENT LLC 13,500$46,0000.03%
Quotient Investors, LLC 13,600$46,0000.03%
View complete list of DICERNA PHARMACEUTICALS INC shareholders